CN102824380B - Application of Lianzhi anti-inflammation dropping pills in preparing medicine for suppressing HT1080 cell proliferation - Google Patents

Application of Lianzhi anti-inflammation dropping pills in preparing medicine for suppressing HT1080 cell proliferation Download PDF

Info

Publication number
CN102824380B
CN102824380B CN2012103455616A CN201210345561A CN102824380B CN 102824380 B CN102824380 B CN 102824380B CN 2012103455616 A CN2012103455616 A CN 2012103455616A CN 201210345561 A CN201210345561 A CN 201210345561A CN 102824380 B CN102824380 B CN 102824380B
Authority
CN
China
Prior art keywords
pills
cell proliferation
dropping pills
lianzhi
inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2012103455616A
Other languages
Chinese (zh)
Other versions
CN102824380A (en
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HAIMEN JIANGHAI CONSTRUCTION INVESTMENT CO., LTD.
Original Assignee
Nanjing Zhengliang Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Zhengliang Pharmaceutical Technology Co Ltd filed Critical Nanjing Zhengliang Pharmaceutical Technology Co Ltd
Priority to CN2012103455616A priority Critical patent/CN102824380B/en
Publication of CN102824380A publication Critical patent/CN102824380A/en
Application granted granted Critical
Publication of CN102824380B publication Critical patent/CN102824380B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses application of Lianzhi anti-inflammation dropping pills in preparing a medicine for suppressing HT1080 cell proliferation. The prescription of Lianzhi anti-inflammation dropping pills is common andrographis herb dry extract and screwtree root extract with specifications of 30 pills/bag and 6 bags/box; the dropping pills are taken orally, 30 pills once and 3 times per day; the dropping pills can realize the effects of clearing heat, removing toxin, cooling blood and diminishing swelling, and are used for treating the cough and asthma, mumps, acute tonsillitis and throat impediment and sore throat caused by heat and fire toxin in the lung and stomach; and the dropping pills can suppress HT1080 cell proliferation according to the current discovery.

Description

The application of lotus sesame anti-inflammatory dripping pills in preparation inhibition HT1080 cell proliferation medicine
Technical field
The present invention relates to a kind of new purposes of Chinese patent medicine, relate in particular to the application of lotus sesame anti-inflammatory dripping pills in preparation inhibition HT1080 cell proliferation medicine.
Background technology
Fibrosarcoma shows as deeply at the hard fixed joint of single-shot limitation, and the surface is nervous, and light is rubescent, is difficult for ulceration, and surface skin is normal usually, can move, but fixing can not the movement when invading adjacent tissue can infiltrate to subcutaneous fat, muscle, fascia etc.When originating from corium or invading corium afterwards as pathological changes, atrophy, pigmentation and ulceration can occur in surface skin, show as once in a while gill fungus sample lump, multiple infringement can occur near local excision's cicatrix.After repeatedly excising, still common recurrence.After multiple relapse, systemic symptom can appear.Metastasis is found in lung, and occasionally in liver, metastases in local lymph node is rarely found.More pernicious person's tumor is larger, and more soft, makes progress more rapid.Tumor also is found in the baby, has when even being born.Present treatment means effect is all not so good.Lotus sesame anti-inflammatory dripping pills is the exclusive product of Hainan Yi Shun pharmaceutcal corporation, Ltd, does not also have at present it to suppress the bibliographical information of fibrosarcoma (HT1080) cell proliferation.
Summary of the invention
Goal of the invention: the object of the present invention is to provide the application of lotus sesame anti-inflammatory dripping pills in preparation inhibition HT1080 cell proliferation medicine.
Technical scheme: the application of lotus sesame anti-inflammatory dripping pills in preparation inhibition HT1080 cell proliferation medicine.
Lotus sesame anti-inflammatory dripping pills prescription is Herba Andrographis dry extractum (with total andrographolides juice), Radix Helicteris extractum, specification is 30 ball/bags, 6 bags/box, oral, 30 balls, 3 times on the one, the energy heat-clearing and toxic substances removing, the removing heat from blood detumescence, being used for the lung stomach has cough and asthma, mumps, tonsillitis, the sore throat pharyngalgia that in heat, fire-toxin, Sheng causes, finds that now it can suppress the HT1080 cell proliferation.
Beneficial effect: lotus sesame anti-inflammatory dripping pills suppresses the HT1080 cell proliferation, and is respond well.
The specific embodiment
Lotus sesame anti-inflammatory dripping pills suppresses the experimentation data of HT1080 cell proliferation
1 experiment material
1.1 experiment cell strain
Fibrosarcoma (HT1080), from our company's laboratory cell bank, DMEM+10% FBS cellar culture.
1.2 Experimental agents
Drugs: lotus sesame anti-inflammatory dripping pills, Hainan Yi Shun pharmaceutcal corporation, Ltd, lot number: 20110219
The medicinal liquid liquid storage: take 100mg lotus sesame anti-inflammatory dripping pills content, be dissolved in the 5ml dehydrated alcohol, 0.2 μ m filter filters, 500 μ l doff pipe packing, and-20 ℃ of storages, 0.2 μ m filter filters dehydrated alcohol in order to the use of matched group simultaneously.
1.3 experiment reagent
The Cat.No.12100-061 Lot.No.758137 of DMEM(GIBCO company); Hyclone (Hangzhoupro, sky, Zhejiang bio tech ltd Lot.No.100419); NaHCO3(Shanghai hundred million chemical reagent company limited Cat.No.11810-033Lot.No.1088387 of a specified duration); Trypsin(AMRESCO company lot number: 2010/04); EDTA(AMRESCO company lot number: 2009/10); Penicillin G Sodium Salt(AMRESCO company lot number: 2010242); Streptomycin Sulfate(AMRESCO company lot number: 2010382); Dehydrated alcohol (Nanjing Chemistry Reagent Co., Ltd.'s lot number: 080310182); MTT (Biosharp lot number: 0793); The autogamy of PBS(laboratory);
1.4 experiment equipment
Lycra inverted microscope (German Leica model: DM1L); As seen-ultraviolet light microwell plate detector (U.S. MD company model: SPECTRA MAX 190); CO2 incubator (FORMA model: 3111); (safe and sound company of Su Jing group makes model to super-clean bench: SW-CJ-ZFD); Pure water instrument (U.S. Spring company model: S/N 020579); Accurate pipettor (French Gilson Inc model: P2); Electronic balance (German Sai Duolisi company limited model: BT323S); Full-automatic high-pressure autoclave (Japanese SANYO company model: MLS-3020); Table electrothermal air dry oven (Shanghai accurate experimental facilities company model: DHG9123A); Refrigerator (Siemens Company's model: KG18V21TI); Liquid nitrogen container (CBS model: 2001); Low speed centrifuge (Anting Scientific Instrument Factory, Shanghai's model: KA-1000); 0.2 μ m filter (MILLIPORE model: SLGP033RB); 10cm culture dish (NEST company), 96 well culture plates (NEST company); Cell counting count board; Centrifuge tube, pipet, Tips are some.
2 experimental techniques
1) the HT1080 cell carries out cellar culture (10cm culture dish) with DMEM+10% FBS in 37 ℃, 5% CO2, when Growth of Cells during to logarithmic (log) phase, collecting cell discards culture fluid, PBS fine laundering 3 times, add 3ml 0.25% trypsin-0.04%EDTA, after 37 ℃ of digestion 2min, add wherein 5ml complete medium neutralization reaction, after the piping and druming cell, it is changed in centrifuge tube, the centrifugal 5min of 1000rpm adjusts concentration of cell suspension 3 * 10 4Individual/ml.
2) the cell kind is entered in 96 well culture plates, every hole adds cell suspension 180 μ l, culture plate put into cell culture incubator (37 ℃, 5% CO 2) cellar culture.
3) according to the Growth of Cells situation, generally grow to 50%-70%, add lotus sesame anti-inflammatory dripping pills solution, continue to cultivate 24h.
4) add 20 μ l MTT solution (5mg/ml, i.e. 0.5%MTT) after 24h, continue to cultivate 4h.
5) after 4h, the buckle method is removed supernatant, pats dry gently with absorbent paper, and every hole adds 200 μ l dimethyl sulfoxide, puts low-speed oscillation 10min on shaking table, and crystal is fully dissolved.Extinction OD value in each hole of measurement, enzyme-linked immunosorbent assay instrument 490nm place.
6) background (do not add cell, only add culture fluid) is set simultaneously, control wells (the medicine dissolution medium of cell, same concentrations, culture fluid, MTT, dimethyl sulfoxide) is set 6 multiple holes for every group.
7) result represents the value-added suppression ratio of cell with medicine:
Cell increment suppression ratio (%)=(control wells OD value-dosing holes OD value)/control wells OD value * 100%.Experiment repeats 3 times.
3 statistical dispositions
Adopt correlation analysis and Student t check in Microsoft Excel 2003 softwares, data represent with mean ± S.D..
4 experimental results
Statistical result showed after the mtt assay experiment, compare with matched group, when dosage reaches 5mg/ml, to HT1080 cell inhibitory effect variant (P<0.05), dosage this difference when 10mg/ml has significance (P<0.01), and utmost point significant difference (P<0.001) is arranged when dosage reaches 15-20mg/ml.
Table 1 lotus sesame anti-inflammatory dripping pills is on HT1080 cell inhibitory effect impact research
Figure BDA00002151435800031
Figure 2012103455616100002DEST_PATH_IMAGE001
Annotate: compare * P<0.01 with matched group; * P<0.001
5 experiment conclusion
Lotus sesame anti-inflammatory dripping pills can suppress the HT1080 cell proliferation, reduces the Growth of Cells number of HT1080 cell, and this effect is dose dependent.

Claims (1)

1. the application of lotus sesame anti-inflammatory dripping pills in preparation inhibition HT1080 cell proliferation medicine, lotus sesame anti-inflammatory dripping pills is produced by Hainan Yi Shun pharmaceutcal corporation, Ltd, prescription is Herba Andrographis dry extractum, Radix Helicteris extractum, and specification is 30 ball/bags, 6 bags/box, oral, 30 balls, 3 times on the one, the energy heat-clearing and toxic substances removing, the removing heat from blood detumescence, being used for the lung stomach has cough and asthma, mumps, tonsillitis, the sore throat pharyngalgia that in heat, fire-toxin, Sheng causes.
CN2012103455616A 2012-09-18 2012-09-18 Application of Lianzhi anti-inflammation dropping pills in preparing medicine for suppressing HT1080 cell proliferation Expired - Fee Related CN102824380B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012103455616A CN102824380B (en) 2012-09-18 2012-09-18 Application of Lianzhi anti-inflammation dropping pills in preparing medicine for suppressing HT1080 cell proliferation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012103455616A CN102824380B (en) 2012-09-18 2012-09-18 Application of Lianzhi anti-inflammation dropping pills in preparing medicine for suppressing HT1080 cell proliferation

Publications (2)

Publication Number Publication Date
CN102824380A CN102824380A (en) 2012-12-19
CN102824380B true CN102824380B (en) 2013-11-06

Family

ID=47327826

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012103455616A Expired - Fee Related CN102824380B (en) 2012-09-18 2012-09-18 Application of Lianzhi anti-inflammation dropping pills in preparing medicine for suppressing HT1080 cell proliferation

Country Status (1)

Country Link
CN (1) CN102824380B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1660364A (en) * 2005-01-31 2005-08-31 北京正大绿洲医药科技有限公司 'Lianzhi' anti inflammation drop pill in use for clearing away heat and toxic material and preparation method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1660364A (en) * 2005-01-31 2005-08-31 北京正大绿洲医药科技有限公司 'Lianzhi' anti inflammation drop pill in use for clearing away heat and toxic material and preparation method

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
周鑫磊 等.穿心莲内酯抗炎及抗肿瘤作用的研究进展.《食品与药品》.2008,第10卷(第7期),第52-55页.
杨泽云 等.莲芝消炎胶囊主要药效学研究.《中医药通报*实验研究》.2011,第10卷(第3期),第59-61页.
穿心莲内酯对S180小鼠体内抗肿瘤作用的研究;覃华 等;《科学技术与工程》;20101031;第10卷(第28期);第6971-6974页 *
穿心莲内酯抗炎及抗肿瘤作用的研究进展;周鑫磊 等;《食品与药品》;20081231;第10卷(第7期);第52-55页 *
莲芝消炎胶囊主要药效学研究;杨泽云 等;《中医药通报*实验研究》;20110630;第10卷(第3期);第59-61页 *
覃华 等.穿心莲内酯对S180小鼠体内抗肿瘤作用的研究.《科学技术与工程》.2010,第10卷(第28期),第6971-6974页.

Also Published As

Publication number Publication date
CN102824380A (en) 2012-12-19

Similar Documents

Publication Publication Date Title
CN103784738A (en) Extraction method and application of plant composition containing Maca
CN103816368A (en) Extraction method and application of ginseng-containing plant composition
CN103860802B (en) Preparation method and application of Jieguqili tablet
CN102824380B (en) Application of Lianzhi anti-inflammation dropping pills in preparing medicine for suppressing HT1080 cell proliferation
CN105030868A (en) Extraction method for plant composition containing silybum marianum and application of plant composition
CN104983967A (en) Preparation method and application of nasal comforting tablets
CN103690756B (en) A kind of application of Qingfeiyihuo Tablets and preparation method
CN103479749B (en) Preparation method and application of Gegenqinlian tablet
CN102824406B (en) The red capsule for freeing collateral vessels of dragon suppresses the application in MJ cell proliferation in preparation
CN105055805A (en) Extraction method and application of herbal composition containing herba andrographitis
CN102824614A (en) Application of Wujin tablets for preparing medicines for suppressing PC-3 cell proliferation
CN102824515B (en) Application of Reduqing pills in preparation of medicine for inhibiting A-204 cell proliferation
CN103721136B (en) A kind of preparation method of Yanyan slice and application
CN103463581B (en) The preparation method of a kind of cholagogic and lithagogue tablet and application
CN103520266B (en) Preparation method and application of pill containing Pogostemon patchouli and pulvis fellis suis
CN103721071B (en) A kind of preparation method of YULU Baofei bolus and application
CN105106570A (en) Extraction method and application of garlic-containing plant combination
CN103479812B (en) A kind of preparation method of children clearing heat sheet and application
CN103638489B (en) Preparation method and application of kidney-tonifying pills
CN102824517B (en) Application of suoquan capsules in preparing medicines for suppressing OS-732 cell proliferation
CN103720775B (en) The preparation method of a kind of pill for activating blood circulation and application
CN102836215B (en) Folium Crossostephii Chinensis capsule suppresses the application in A875 cell proliferation in preparation
CN103623212B (en) A kind of preparation method and application consolidating ball
CN103494930A (en) Preparation method and application of compound houttuynia cordata tablets
CN103494933B (en) Preparation method and application of liver protection tablet

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: XINXIANG COLLEGE OF MEDICAL SCIENCE

Free format text: FORMER OWNER: NANJING ZHENGLIANG PHARMACEUTICAL TECHNOLOGY CO., LTD.

Effective date: 20131017

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Di Desheng

Inventor after: Zhao Erqi

Inventor after: Gui Lihui

Inventor after: Xu Zhongjie

Inventor after: Liu Wei

Inventor after: Yuan Huifeng

Inventor after: Gu Zheng

Inventor after: Li Songji

Inventor after: Hou Tiantian

Inventor after: He Huanhuan

Inventor before: The inventor has waived the right to be mentioned

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 211300 NANJING, JIANGSU PROVINCE TO: 453003 XINXIANG, HENAN PROVINCE

Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: ZHAI DESHENG GUI LIHUI XU ZHONGJIE LIU WEI YUAN HUIFENG GU ZHENG LI SONGJI HOU TIANTIAN HE HUANHUAN ZHAO ERQI

TR01 Transfer of patent right

Effective date of registration: 20131017

Address after: No. 601 Xinxiang City, Henan province Jinsui road 453003

Patentee after: Xinxiang Medical College

Address before: Gu Tan Road Economic Development Zone in Gaochun County of Nanjing City, Jiangsu province 211300 branch No. 3 Building Room 607

Patentee before: Nanjing Zhengliang Medical Technology Co.,Ltd.

ASS Succession or assignment of patent right

Owner name: NANJING ZHENGLIANG PHARMACEUTICAL TECHNOLOGY CO.,

Free format text: FORMER OWNER: XINXIANG COLLEGE OF MEDICAL SCIENCE

Effective date: 20131126

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 453003 XINXIANG, HENAN PROVINCE TO: 211300 NANJING, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20131126

Address after: Gu Tan Road Economic Development Zone in Gaochun County of Nanjing City, Jiangsu province 211300 branch No. 3 Building Room 607

Patentee after: Nanjing Zhengliang Medical Technology Co.,Ltd.

Address before: No. 601 Xinxiang City, Henan province Jinsui road 453003

Patentee before: Xinxiang Medical College

ASS Succession or assignment of patent right

Owner name: HAIMEN JIANGHAI CONSTRUCTION INVESTMENT CO., LTD.

Free format text: FORMER OWNER: NANJING ZHENGLIANG PHARMACEUTICAL TECHNOLOGY CO., LTD.

Effective date: 20140627

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 211300 NANJING, JIANGSU PROVINCE TO: 226100 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20140627

Address after: 226100, 999, Guangzhou Road, Haimen, Jiangsu, Nantong

Patentee after: HAIMEN JIANGHAI CONSTRUCTION INVESTMENT CO., LTD.

Address before: Gu Tan Road Economic Development Zone in Gaochun County of Nanjing City, Jiangsu province 211300 branch No. 3 Building Room 607

Patentee before: Nanjing Zhengliang Medical Technology Co.,Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131106

Termination date: 20170918

CF01 Termination of patent right due to non-payment of annual fee